Neoadjuvant immunotherapy (NIO) is used as a first step cancer treatment that aims to shrink tumours before surgery or any other major treatment. It induces a stronger immune reaction than adjuvant immunotherapy, which is administered after primary surgery, because there are more tumour cells present. NIO encourages the immune system ...